Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Clonal Heterogeneity of Acute Myeloid Leukemia Treated with the IDH2 inhibitor Enasidenib

Vyas P., Quek L., David M., Kennedy A., Metzner M., Amatangelo M., Shih A., Stoilova B., Quivoron C., Heiblig M., Willekens C., Saada V., Alsafadi S., Vijayabaskar M., Peniket A., Bernard O., Agresta S., Yen K., MacBeth K., Stein E., Vassiliou G., Levine R., De Botton S., Thakurta A., Penard-Lacronique V.